You are viewing an obsolete version of the DU website which is no longer supported by the Administrators. Visit The New DU.
Democratic Underground Latest Greatest Lobby Journals Search Options Help Login
Google

Reply #7: here you go [View All]

Printer-friendly format Printer-friendly format
Printer-friendly format Email this thread to a friend
Printer-friendly format Bookmark this thread
This topic is archived.
Home » Discuss » Topic Forums » Health Donate to DU
leftchick Donating Member (1000+ posts) Send PM | Profile | Ignore Tue Jul-03-07 04:46 PM
Response to Reply #3
7. here you go
http://www.corpwatch.org/article.php?id=14401


Testing in the Third World

JayaJan Pharmaceutical Research in India was one of the companies with which Merck had a contract to test Gardasil. Like most of the industry, Merck increasingly outsources its clinical trials to Contract Research Organizations (CROs) in areas of the world where trial subjects are plentiful, operating costs are low, and regulations lax.

Some $285 million worth of clinical trials are outsourced to CROs in India, according to biopeer.com. These CROs are a booming $15 billion industry whose revenues are rising at 15 percent a year.

"CROs are known for their speed and efficiency; they can complete a clinical trial in two-thirds the time a drug company can, shaving months off the process and offering $120 million to $150 million in increased revenue per drug." Sam Bidwell an executive with Quintiles a U.S.-based CRO told Nature. "Of the top 30 best-selling drugs, we've touched every one."

Critics point out that CROs can come with built-in problems. Conflicts of interest can arise when CROs are paid royalties only after a drug is approved rather than being paid a set fee that is independent of how safe or effective the drug turns out to be. Problems can also arise because CROs know that favorable findings mean that research into a test drug will continue, and they may also believe that results that please the hiring corporation can lead to future contracts. "ompanies know that the farther the compound moves through the research cycle, the more money they can raise," Nature reported.

Merck spokesperson Amy Rose refused say how many trials Merck contracted to CROs or what percentage of the Gardasil subjects these contractors recruited in the Third World. She also refused to specify how, or even if, the company oversees CROs.
Printer Friendly | Permalink |  | Top
 

Home » Discuss » Topic Forums » Health Donate to DU

Powered by DCForum+ Version 1.1 Copyright 1997-2002 DCScripts.com
Software has been extensively modified by the DU administrators


Important Notices: By participating on this discussion board, visitors agree to abide by the rules outlined on our Rules page. Messages posted on the Democratic Underground Discussion Forums are the opinions of the individuals who post them, and do not necessarily represent the opinions of Democratic Underground, LLC.

Home  |  Discussion Forums  |  Journals |  Store  |  Donate

About DU  |  Contact Us  |  Privacy Policy

Got a message for Democratic Underground? Click here to send us a message.

© 2001 - 2011 Democratic Underground, LLC